Health inequities in the rheumatic diseases of childhood.


Journal

Current opinion in rheumatology
ISSN: 1531-6963
Titre abrégé: Curr Opin Rheumatol
Pays: United States
ID NLM: 9000851

Informations de publication

Date de publication:
01 09 2022
Historique:
pubmed: 8 7 2022
medline: 28 7 2022
entrez: 7 7 2022
Statut: ppublish

Résumé

To describe differences in disease manifestations and outcomes in pediatric rheumatic diseases as they occur in non-European-descended populations in North America. Differences in disease prevalence, clinical phenotypes, disease course, and outcomes have been described across the spectrum of pediatric-onset rheumatic diseases. Although these differences are commonly explained by differences in genetic risk or access to tertiary healthcare facilities, our emerging understanding of the immunobiology of historical/ongoing trauma suggest a more complex explanation for these observed differences. Health inequities as observed in pediatric rheumatic diseases are likely to emerge from a complex interplay between social and biological factors. The important contribution of historical and repetitive trauma deserves further exploration.

Identifiants

pubmed: 35797523
doi: 10.1097/BOR.0000000000000893
pii: 00002281-202209000-00004
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

262-266

Informations de copyright

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Références

Wright JL, Freed GL, Hendricks-Muñoz KD, et al. Achieving equity through science and integrity: dismantling race-based medicine. Pediatr Res 2022; 91:1641–1644.
Khondra B, Stevens A, Ferucci ED. Prevalence of juvenile idiopathic arthritis in the Alaska Native population. Arthritis Care Res (Hoboken) 2020; 72:1152–1158.
Fitzpatrick L, Broadaway KA, Ponder L, et al. CARRA Registry Investigators. Phenotypic characterization of juvenile idiopathic arthritis in African American children. J Rheumatol 2016; 43:799–803.
Schwartz MM, Simpson P, Kerr KL, Jarvis JN. Juvenile rheumatoid arthritis in African Americans. J Rheumatol 1997; 24:1826–1829.
Oen K, Schroeder M, Jacobson K, et al. Juvenile rheumatoid arthritis in a Canadian First Nations (aboriginal) population: onset subtypes and HLA associations. J Rheumatol 1998; 25:783–790.
Mauldin J, Cameron HD, Jeanotte D, et al. Chronic arthritis in children and adolescents in two Indian health service user populations. BMC Musculoskelet Disord 2004; 5:30.
Zaripova LN, Midgley A, Christmas SE, et al. Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches. Pediatr Rheumatol Online J 2021; 19:135.
Hinks A, Marion MC, Cobb J, et al. Brief report: the genetic profile of rheumatoid factor-positive polyarticular juvenile idiopathic arthritis resembles that of adult rheumatoid arthritis. Arthritis Rheumatol 2018; 70:957–962.
Ringold S, Beukelman T, Nigrovic PA, Kimura Y. CARRA Registry Site Principal Investigators. Race, ethnicity, and disease outcomes in juvenile idiopathic arthritis: a cross-sectional analysis of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry. J Rheumatol 2013; 40:936–942.
Chang JC, Xiao R, Burnham JM, Weiss PF. Longitudinal assessment of racial disparities in juvenile idiopathic arthritis disease activity in a treat-to-target intervention. Pediatr Rheumatol Online J 2020; 18:88.
Dall’Era M, Cisternas MG, Snipes K, et al. The incidence and prevalence of systemic lupus erythematosus in San Francisco County, California: the California Lupus Surveillance Project. Arthritis Rheumatol 2017; 69:1996–2005.
Lim SS, Bayakly AR, Helmick CG, et al. The incidence and prevalence of systemic lupus erythematosus, 2002–2004: the Georgia Lupus Registry. Arthritis Rheumatol 2014; 66:357–368.
Ferucci ED, Johnston JM, Gaddy JR, et al. Prevalence and incidence of systemic lupus erythematosus in a population-based registry of American Indian and Alaska Native people. Arthritis Rheumatol 2014; 66:2494–2502.
Houghton KM, Page J, Cabral DA, et al. Systemic lupus erythematosus in the pediatric North American Native population of British Columbia. J Rheumatol 2006; 33:161–163.
Hiraki LT, Benseler SM, Tyrrell PN, et al. Ethnic differences in pediatric systemic lupus erythematosus. J Rheumatol 2009; 36:2539–2546.
Tucker LB, Uribe AG, Fernández M, et al. Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII). Lupus 2008; 17:314–322.
Mendez EP, Lipton R, Ramsey-Goldman R, et al. NIAMS Juvenile DM Registry Physician Referral Group. US incidence of juvenile dermatomyositis, 1995–1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. Arthritis Rheum 2003; 49:300–305.
Phillippi K, Hoeltzel M, Byun Robinson A, Kim S. Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry Investigators. Race, Income, and Disease Outcomes in Juvenile Dermatomyositis. J Pediatr 2017; 184:38.e1–44.e1.
Bowyer SL, Blane CE, Sullivan DB, Cassidy JT. Childhood dermatomyositis: factors predicting functional outcome and development of dystrophic calcification. J Pediatr 1983; 103:882–888.
Willkens RF, Nepom GT, Marks CR, et al. Association of HLA-Dw16 with rheumatoid arthritis in Yakima Indians. Further evidence for the ‘shared epitope’ hypothesis. Arthritis Rheum 1991; 34:43–47.
Reynolds RJ, Ahmed AF, Danila MI, Hughes LB. HLA-DRB1-associated rheumatoid arthritis risk at multiple levels in African Americans: hierarchical classification systems, amino acid positions, and residues. Arthritis Rheumatol 2014; 66:3274–3282.
Danila MI, Laufer VA, Reynolds RJ, et al. Dense genotyping of immune-related regions identifies loci for rheumatoid arthritis risk and damage in African Americans. Mol Med 2017; 23:177–187.
Peschken CA, Esdaile JM. Rheumatic diseases in North America's indigenous peoples. Semin Arthritis Rheum 1999; 28:368–391.
Sánchez E, Comeau ME, Freedman BI, et al. Identification of novel genetic susceptibility loci in African American lupus patients in a candidate gene association study. Arthritis Rheum 2011; 63:3493–3501.
Ishigaki K, Akiyama M, Kanai M, et al. Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases. Nat Genet 2020; 52:669–679.
Bhatt J, Bathija P. Ensuring access to quality healthcare in vulnerable communities. Acad Med 2018; 93:1271–1275.
Wright JL, Jarvis JN, Pachter LM, Walker-Harding LR. ‘Racism as a public health issue’ APS racism series: at the intersection of equity, science, and social justice. Pediatr Res 2020; 88:696–698.
Felitti VJ, Anda RF, Nordenberg D, et al. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The Adverse Childhood Experiences (ACE) Study. Am J Prev Med 1998; 14:245–258.
Mahmood SS, Levy D, Vasan RS, Wang TJ. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet 2014; 383:999–1008.
Weiss MJ, Wagner SH. What explains the negative consequences of adverse childhood experiences on adult health? Insights from cognitive and neuroscience research. Am J Prev Med 1998; 14:356–360.
Anda RF, Whitfield CL, Felitti VJ, et al. Adverse childhood experiences, alcoholic parents, and later risk of alcoholism and depression. Psychiatr Serv 2002; 53:1001–1009.
Baumer Y, Powell-Wiley TM. Interdisciplinary approaches are fundamental to decode the biology of adversity. Cell 2021; 184:2797–2801.
Berens AE, Jensen SKG, Nelson CA 3rd. Biological embedding of childhood adversity: from physiological mechanisms to clinical implications. BMC Med 2017; 15:135.
Chen MA, LeRoy AS, Majd M, et al. Immune and epigenetic pathways linking childhood adversity and health across the lifespan. Front Psychol 2021; 12:788351.
Elwenspoek MMC, Kuehn A, Muller CP, Turner JD. The effects of early life adversity on the immune system. Psychoneuroendocrinology 2017; 82:140–154.
Ferucci ED, Templin DW, Lanier AP. Rheumatoid arthritis in American Indians and Alaska natives: a review of the literature. Semin Arthritis Rheum 2005; 34:662–667.
Warne D, Dulacki K, Spurlock M, et al. Adverse Childhood Experiences (ACE) among American Indians in South Dakota and associations with mental health conditions, alcohol use, and smoking. J Healthcare Poor Underserved 2017; 28:1559–1577.
Luiz APL, Antico HA, Skare TL, et al. Adverse childhood experience and rheumatic diseases. Clin Rheumatol 2018; 37:2863–2867.
Dube SR, Fairweather D, Pearson WS, et al. Cumulative childhood stress and autoimmune diseases in adults. Psychosom Med 2009; 71:243–250.
Rubinstein TB, Bullock DR, Ardalan K, et al. Adverse childhood experiences are associated with childhood-onset arthritis in a national sample of US youth: an analysis of the 2016 National Survey of Children's Health. J Pediatr 2020; 226:243.e2–250.e2.
Sonagra M, Jones J, McGill M, Gmuca S. Exploring the intersection of adverse childhood experiences, pediatric chronic pain, and rheumatic disease. Pediatr Rheumatol 2022; 20:14.
DeQuattro K, Trupin L, Li J, et al. Relationships between adverse childhood experiences and health status in systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2020; 72:525–533.

Auteurs

Danielle K Falkenstein (DK)

Jacobs School of Medicine & Biomedical Sciences.

James N Jarvis (JN)

Department of Pediatrics.
Genetics, Genomics, & Bioinformatics Program, University at Buffalo, Buffalo, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH